Our Faculty
David Mischoulon, M.D., Ph.D.
Director, Depression Clinical and Research Program, Massachusetts General Hospital
Professor of Psychiatry Harvard Medical School
Biography
Dr. David Mischoulon graduated in 1994 from the combined M.D./Ph.D. program at Boston University School of Medicine. He completed an internship in General Medicine at Carney Hospital in 1995. He then entered the Massachusetts General Hospital (MGH) Adult Psychiatry Residency Training Program, from which he graduated in 1998, after serving as Chief Resident in Psychopharmacology. He is a professor of Psychiatry at Harvard Medical School (HMS), and Director of the Depression Clinical and Research Program (DCRP) of MGH.
His research has focused on various areas of depression, including complementary and alternative medicine. He is also an accredited medical acupuncturist and has carried out studies of acupuncture as a treatment for depression. He has received two NARSAD Young Investigator awards, a K-23 award from NCCAM, an R01 grant from the National Institute for Health (NIH) to study omega-3 fatty acids for depression, and a UG3 from NCCIH to continue the latter work. He has mentored many research fellows and junior faculty, including investigators from Europe, Asia, and Australia, who have gone on to obtain independent funding as principal investigators.
Dr. Mischoulon has authored or coauthored more than 240 original articles, review articles, and book chapters. He has coedited a textbook on natural medications for psychiatric disorders, and is coediting an MGH guide to treatments of depression. He has been an invited speaker at various sites around the country and internationally, and has won several awards, including appointment as a Distinguished Fellow of the Massachusetts Psychiatric Society and the American Psychiatric Association.
In addition to his research activities, he has been an active teacher in the MGH Department of Psychiatry’s residency program and various continuing medical education programs. He also cares for patients through the DCRP clinical practice, and is regularly sought out for consultation regarding management of treatment-resistant depression and use of complementary therapies for psychiatric disorders.